Q-linea
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Q-linea
- Stuart Gander, Chief Executive Officer
- Mario Gualano, Director
- Erika Eriksson, Chairman of the Board
Popular executive movements at Q-linea
- Jonas Jarvius, Chief Executive Officer, will leave the company on Mar. 1, 2024 (posted on January 23 2024).
- Stuart Gander will join the company as Chief Executive Officer on Mar. 1, 2024 (posted on January 23 2024).
Create your alert
to follow the executive moves at Q-linea.
Biotechnology
Q-linea has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Q-linea
- News and events | Q-lineaNews and events | Q-linea
- Press releases | Q-lineaPress releases | Q-linea
- Press releases | Q-lineaPress releases | Q-linea
- Pressmeddelanden | Q-lineaPressmeddelanden | Q-linea
- Press releases about IPO | Q-lineaPress releases about IPO | Q-linea
Social media about Q-linea
- Q-linea on Wikipedia, Google News & Yahoo Finance
- Q-linea on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Stuart Gander 
